Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population (original) (raw)

References

• Abbott RT, Tripp S, Perkins SL, Elenitoba-Johnson KS, Lim MS . (2003). Analysis of the PI-3-Kinase-PTEN-AKT pathway in human lymphoma and leukemia using a cell line microarray. Mod Pathol 16: 607–612.
  Article PubMed Google Scholar
• Abubaker J, Bavi PP, Al-Harbi S, Siraj AK, Al-Dayel F, Uddin S et al. (2007). PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma. Leukemia 21: 2368–2370.
  Article CAS PubMed Google Scholar
• Bader AG, Kang S, Zhao L, Vogt PK . (2005). Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 5: 921–929.
  Article CAS PubMed Google Scholar
• Bavi P, Jehan Z, Atizado V, Al-Dossari H, Al-Dayel F, Tulbah A et al. (2006). Prevalence of fragile histidine triad expression in tumors from Saudi Arabia: a tissue microarray analysis. Cancer Epidemiol Biomarkers Prev 15: 1708–1718.
  Article CAS PubMed Google Scholar
• Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW et al. (1998). A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248–5257.
  CAS PubMed Google Scholar
• Bose S, Chandran S, Mirocha JM, Bose N . (2006). The Akt pathway in human breast cancer: a tissue-array-based analysis. Mod Pathol 19: 238–245.
  Article CAS PubMed Google Scholar
• Bose S, Crane A, Hibshoosh H, Mansukhani M, Sandweis L, Parsons R . (2002). Reduced expression of PTEN correlates with breast cancer progression. Hum Pathol 33: 405–409.
  Article CAS PubMed Google Scholar
• Bray F, Sankila R, Ferlay J, Parkin DM . (2002). Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 38: 99–166.
  Article CAS PubMed Google Scholar
• Broderick DK, Di C, Parrett TJ, Samuels YR, Cummins JM, McLendon RE et al. (2004). Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas. Cancer Res 64: 5048–5050.
  Article CAS PubMed Google Scholar
• Campbell IG, Russell SE, Choong DY, Montgomery KG, Ciavarella ML, Hooi CS et al. (2004). Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res 64: 7678–7681.
  Article CAS PubMed Google Scholar
• Cully M, You H, Levine AJ, Mak TW . (2006). Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6: 184–192.
  Article CAS PubMed Google Scholar
• El-Hazmi MA, Al-Swailem AR, Warsy AS, Al-Swailem AM, Sulaimani R, Al-Meshari AA . (1995). Consanguinity among the Saudi Arabian population. J Med Genet 32: 623–626.
  Article CAS PubMed PubMed Central Google Scholar
• Frattini M, Signoroni S, Pilotti S, Bertario L, Benvenuti S, Zanon C et al. (2005). Phosphatase protein homologue to tensin expression and phosphatidylinositol-3 phosphate kinase mutations in colorectal cancer. Cancer Res 65: 11227.
  Article CAS PubMed Google Scholar
• Garcia Z, Kumar A, Marques M, Cortes I, Carrera AC . (2006). Phosphoinositide 3-kinase controls early and late events in mammalian cell division. EMBO J 25: 655–661.
  Article CAS PubMed PubMed Central Google Scholar
• Isbister WH, Murad M, Habib Z . (2000). Rectal cancer in the Kingdom of Saudi Arabia: the King Faisal Specialist Hospital experience. Aust NZ J Surg 70: 269–274.
  Article CAS Google Scholar
• Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S et al. (1998). Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844–847.
  Article CAS PubMed Google Scholar
• Lee JW, Soung YH, Kim SY, Lee HW, Park WS, Nam SW et al. (2005). PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene 24: 1477–1480.
  Article CAS PubMed Google Scholar
• Levine DA, Bogomolniy F, Yee CJ, Lash A, Barakat RR, Borgen PI et al. (2005). Frequent mutation of the PIK3CA gene in ovarian and breast cancers. Clin Cancer Res 11: 2875–2878.
  Article CAS PubMed Google Scholar
• Li VS, Wong CW, Chan TL, Chan AS, Zhao W, Chu KM et al. (2005). Mutations of PIK3CA in gastric adenocarcinoma. BMC Cancer 5: 29.
  Article PubMed PubMed Central Google Scholar
• Maruyama N, Miyoshi Y, Taguchi T, Tamaki Y, Monden M, Noguchi S . (2007). Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women. Clin Cancer Res 13: 408–414.
  Article CAS PubMed Google Scholar
• Nassif NT, Lobo GP, Wu X, Henderson CJ, Morrison CD, Eng C et al. (2004). PTEN mutations are common in sporadic microsatellite stable colorectal cancer. Oncogene 23: 617–628.
  Article CAS PubMed Google Scholar
• Ollikainen M, Gylling A, Puputti M, Nupponen NN, Abdel-Rahman WM, Butzow R et al. (2007). Patterns of PIK3CA alterations in familial colorectal and endometrial carcinoma. Int J Cancer 121: 915–920.
  Article CAS PubMed Google Scholar
• Philp AJ, Phillips WA, Rockman SP, Vincan E, Baindur-Hudson S, Burns W et al. (2000). Microsatellite instability in gastrointestinal tract tumours. Int J Surg Investig 2: 267–274.
  CAS PubMed Google Scholar
• Saal LH, Holm K, Maurer M, Memeo L, Su T, Wang X et al. (2005). PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res 65: 2554–2559.
  Article CAS PubMed Google Scholar
• Samuels Y, Diaz Jr LA, Schmidt-Kittler O, Cummins JM, Delong L, Cheong I et al. (2005). Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7: 561–573.
  Article CAS PubMed Google Scholar
• Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S et al. (2004). High frequency of mutations of the PIK3CA gene in human cancers. Science 304: 554.
  Article CAS PubMed Google Scholar
• Singh B, Reddy PG, Goberdhan A, Walsh C, Dao S, Ngai I et al. (2002). p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas. Genes Dev 16: 984–993.
  Article CAS PubMed PubMed Central Google Scholar
• Toyota M, Itoh F, Imai K . (2000). DNA methylation and gastrointestinal malignancies: functional consequences and clinical implications. J Gastroenterol 35: 727–734.
  Article CAS PubMed Google Scholar
• Uddin S, Hussain AR, Siraj AK, Manogaran PS, Al-Jomah NA, Moorji A et al. (2006). Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Blood 108: 4178–4186.
  Article CAS PubMed Google Scholar
• Velho S, Oliveira C, Ferreira A, Ferreira AC, Suriano G, Schwartz Jr S et al. (2005). The prevalence of PIK3CA mutations in gastric and colon cancer. Eur J Cancer 41: 1649–1654.
  Article CAS PubMed Google Scholar
• Vivanco I, Sawyers CL . (2002). The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489–501.
  Article CAS PubMed Google Scholar
• Wymann MP, Marone R . (2005). Phosphoinositide 3-kinase in disease: timing, location, and scaffolding. Curr Opin Cell Biol 17: 141–149.
  Article CAS PubMed Google Scholar

Download references